Write in a clean editor, then format for Sclerosis in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Sclerosis is a peer-reviewed journal published by MDPI, covering Multiple Sclerosis Research Studies, Systemic Sclerosis and Related Diseases, Amyotrophic Lateral Sclerosis Research. Over its lifetime it has published 101 papers, which have received 156 citations.
| Publisher | MDPI |
|---|---|
| Reference style | Numbered (MDPI) Numbered — [1], [2] in the text 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Sclerosis 2023, 12, 45–58.
Formats any DOI in Sclerosis style. No sign-up. |
| Publishes research in | Multiple Sclerosis Research Studies Systemic Sclerosis and Related Diseases Amyotrophic Lateral Sclerosis Research Peripheral Neuropathies and Disorders Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis |
| ISSN | 2813-3064 |
| Citation impact (2-yr) | 1.28 |
| h-index | 6 |
| i10-index | 3 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Università degli Studi del Piemonte Orientale “Amedeo Avogadro” |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Extracellular vesicles (EVs) are involved in the regulation of immune system functioning and central nervous system (CNS) homeostasis, suggesting a possible role in multiple sclerosis (MS). Indeed, by carrying several types of mediators, such as cytokines, enzymes, and RNAs, EVs can display both anti- and pro-inflammatory roles on the innate and adaptive immune system, and…
Background/Objectives: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the progressive degeneration of motor neurons. The gut microbiota, a community of microorganisms in the digestive tract, has recently been implicated in ALS pathogenesis through its influence on neuroinflammation and metabolic pathways. This review explores the potential role of digestive microbiota and its metabolites…
Background: This pilot study explored the effectiveness and feasibility of an online version of a group acceptance and commitment therapy (ACT) resilience training intervention for people with multiple sclerosis (PwMS), called e-READY for Multiple Sclerosis (MS). Methods: Fifty-six PwMS were randomized to intervention (n = 31) or waitlist control (WLC) (n = 25). The primary…
Pediatric onset multiple sclerosis (POMS), characterized by the onset of multiple sclerosis before the age of 18, is gaining increased recognition. Approximately 5 percent of MS cases manifest before the age of 18, with less than 1 percent occurring before the age of 10. Despite its rarity, pediatric MS exhibits distinct characteristics, with an association…
Multiple sclerosis (MS) is an inflammatory demyelinating disease affecting the central nervous system (CNS). In MS, oligodendrocytes and myelin that surround axons to facilitate transmission of neuronal signals are destroyed by adaptive and innate immune cells, resulting in the formation of demyelinating plaques. For many years, research into MS pathophysiology has identified immune cell populations…
